Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
SOLVSolventum
FinDog View：Neutral
| Metric | GILD | SOLV |
|---|
| Close | 147.68 | 88.83 |
| Market Cap | $183B | $15.1B |
| 1M | +6.31% | +2.32% |
| P/E (TTM) | — | 10.7 |
| Forward P/E | 25.3 | 12.4 |
| P/E 5-Yr Percentile | — | 48 |
| P/S | 6.0 | 1.8 |
| P/B | 15.3 | 3.2 |
| Dividend Yield | 3.98% | — |
| Latest Quarter Revenue | $7.8B | $2.2B |
| Revenue YoY | +10.2% | +2.2% |
| Gross Margin | 79.8% | — |
| Latest Quarter EPS | -8.45 | 0.53 |
| Avg Post-Earnings Move | ±3.8% | ±4.5% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.01% | 2.35% |
| 90-Day Net Insider Buying | −$15.4M | — |
GILD · Revenue, Last 8 Quarters ($B)
SOLV · Revenue, Last 8 Quarters ($B)
